Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) shares gained 0.73% to $7.36. ARIAD Pharmaceuticals, Inc. (ARIA) and Medinol, Ltd. on Jan. 14 announced the initiation of two registration trials of...
Integrated oncology services Biologics would be the sole specialty provider of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s drug Iclusig. It would also be managing the Patient Access as...
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) shares climbed 4.64% to $6.76. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines...
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares climbed 4.53% to $5.77 in the pre-market hour. The European Medicines Agency on Dec. 17 said it will review Ariad’s Iclusig...
Twitter Inc (NYSE:TWTR) shares dropped 1.67% to $55.51. On Dec. 16, Bob Peck from SunTrust downgraded shares of Twitter from Buy to Hold also as a...
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares climbed 12.69% to $4.32. Levi & Korsinsky on Dec. 5 announces that a class action lawsuit has been commenced in the...
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) would be coming out with its quarterly earnings report soon and investors have witnessed the stock taking a hit due to bad news...